Charles J. Casamento

Charles J. Casamento is recorded as Board Member at GT Biopharma, Inc. (GTBP), Board Member at Eton Pharmaceuticals, Inc. (ETON), Board Member at Relmada Therapeutics, Inc. (RLMD) since May 25, 2023 and Chairman at Relmada Therapeutics, Inc. (RLMD). The newest filing on record that lists Charles J. Casamento as Board Member at GT Biopharma, Inc. (GTBP) is dated July 2, 2026. The newest filing on record that lists Charles J. Casamento as Board Member at Eton Pharmaceuticals, Inc. (ETON) is dated April 24, 2026. GridAI Technologies Corp. reported in an 8-K filed August 7, 2024 that Charles J. Casamento resigned as member of the Board of the Company, effective August 2, 2024. Relmada Therapeutics, Inc. reported in an 8-K filed May 25, 2023 that Charles J. Casamento was appointed Class II Director, effective May 25, 2023. GT Biopharma, Inc. reported in an 8-K filed May 4, 2023 that Charles J. Casamento was appointed member of the Board of Directors, effective May 1, 2023. Eton Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. GT Biopharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Eton Pharmaceuticals, Inc. includes Sean Brynjelsen (CEO and Board Member), Norbert G. Riedel (Chairman), James Gruber (CFO) and 4 others.